Related Experiment Videos

Two cases of retroperitoneal haematoma caused by interaction between antibiotics and warfarin

S Phillips1, A Barr, E Wilson

  • 1Department of Surgery, Royal Surrey County Hospital, Egerton Road, Guildford, Surrey GU2 7XX, UK. drsimonphillips@hotmail.com

Emergency Medicine Journal : EMJ
|December 24, 2005
PubMed

Insights

Certain antibiotics can increase warfarin's anticoagulant effect, raising the risk of dangerous retroperitoneal bleeding. This complication, potentially fatal, requires careful monitoring of patients on both medications.

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Clinical Toxicology

Background:

  • Warfarin is a widely prescribed anticoagulant.
  • Drug interactions with warfarin can alter its efficacy and safety.
  • Antibiotic use is common in patients taking warfarin.

Observation:

  • Several antibiotics potentiate warfarin's anticoagulant effect through various mechanisms.
  • Over-anticoagulation with warfarin can lead to serious adverse events.
  • Retroperitoneal bleeding and hematoma formation are recognized complications.

Findings:

  • Antibiotic-warfarin interactions can significantly increase the risk of bleeding.
  • Retroperitoneal hemorrhage presents a potentially fatal complication.
  • Consequences include hypovolemic shock and compression of vital retroperitoneal structures.

Implications:

  • Clinicians must be aware of potential antibiotic-warfarin interactions.
  • Careful patient monitoring is crucial when prescribing antibiotics to warfarin users.
  • Strategies to mitigate bleeding risk in this patient population are warranted.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...